Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Tianyin Wins SFDA Approval for Antibiotic

publication date: Mar 17, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical, Co., Inc. continues the rapid pace of its news flow with an announcement that the SFDA approved the company’s generic form of antibiotic medicine Azithromycin Dispersible Tablets. For Tianyin, the approval was the first the company has received from the SFDA, and the drug will become the third Western-style drug in the portfolio. Most of Tianyin’s products are traditional Chinese medicines. To further diversify its product line, Tianyin has another 10 products awaiting SFDA approval. More details...

Stock Symbol: (OTCBB: TYNP) (NYSE: PFE)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors